从步态数据中检测出早期的帕金森病
Parvathy Nair1,2,3, Maryam Shojaei Baghini2, Gita Pendharkar3
1IITB-Monash Research Academy, Mumbai, Maharashtra, India.
概括
动态时间扭曲 (DTW) 通过分析步态模式,有效检测早期帕金森病 (PD). 这种方法的准确性超过98%,有助于及时诊断和开始治疗这种神经退行性疾病.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 数据科学数据科学数据科学
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,影响全球数百万人.
- 早期的PD症状是微妙的,经常错过,延迟诊断和治疗.
- 当前的诊断方法在早期检测微小的步态变化方面存在困难.
研究的目的:
- 开发和验证一种使用步态分析早期检测和分类帕金森病的新方法.
- 为了应对在早期PD患者中识别细微步态变化的挑战.
- 提高诊断准确度,促进PD早期干预.
主要方法:
- 利用动态时间扭曲 (DTW) 来计算步态周期之间的差异,捕捉微妙的时间变化.
- 使用K-means集群在DTW衍生的时间扭曲信息上提取的步态特征.
- 使用后勤回归进行分类,在166名受试者 (83名早期PD,10名中度PD,73名对照) 的数据集上通过Leave-One-Out和N-fold交叉验证进行验证.
主要成果:
- 在早期PD症状方面,检测准确度超过98%.
- 证明了基于DTW的功能对步行风格和速度的变化具有强大的耐受性.
- 成功地分类了早期PD症状,超过了传统的统计特征.
结论:
- 来自DTW的步态特征为早期PD检测提供了一种高度准确和可靠的方法.
- 这种方法可以显著帮助临床医生在早期诊断PD时.
- 通过先进的步态分析进行早期诊断可以导致及时治疗,从而有可能减少症状的严重程度.
更多相关视频
04:08Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease
Published on: January 18, 2021
2.8K
06:25Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits
Published on: August 12, 2019
8.5K
相关概念视频
01:24Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
01:15Parkinson's Disease: Overview
564
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
564